BETA-AMYLOID((1-42)) AFFECTS CHOLINERGIC BUT NOT PARVALBUMIN-CONTAINING NEURONS IN THE SEPTAL COMPLEX OF THE RAT

被引:58
作者
HARKANY, T
DEJONG, GI
SOOS, K
PENKE, B
LUITEN, PGM
GULYA, K
机构
[1] ATTILA JOZSEF UNIV, DEPT ZOOL & CELL BIOL, H-6722 SZEGED, HUNGARY
[2] ALBERT SZENT GYORGYI MED UNIV, DEPT MED CHEM, H-6701 SZEGED, HUNGARY
[3] UNIV GRONINGEN, DEPT ANIM PHYSIOL, 9750 AA HAREN, NETHERLANDS
基金
匈牙利科学研究基金会;
关键词
BETA-AMYLOID; CALCIUM-BINDING PROTEIN; CHOLINE ACETYLTRANSFERASE; CHOLINOTOXICITY; MEDIAL SEPTUM; PARVALBUMIN;
D O I
10.1016/0006-8993(95)01013-L
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta-Amyloid((1-42)) peptide (beta AP((1-42))) was injected into the medial septum of rats. After a 14-day survival time, neuronal alterations in the septal cholinergic and GABAergic systems were visualized by means of histo- and immunocytochemical methods. Neurons insulted by the peptide were primarily choline acetyltransferase-immunoreactive (ir), while only minor effects of beta AP((1-42)) were observed on parvalbumin-ir interneurons. These results indicate that the changes in intracellular Ca2+ level elicited by beta AP((1-42)) may contribute to beta-amyloid neurotoxicity, and Ca2+-binding proteins may play an important role in the protection against the neurotoxic effects of beta AP((1-42)).
引用
收藏
页码:270 / 274
页数:5
相关论文
共 25 条
[1]   ADMINISTRATION OF AMYLOID BETA-PEPTIDES INTO THE MEDIAL SEPTUM OF RATS DECREASES ACETYLCHOLINE-RELEASE FROM HIPPOCAMPUS IN-VIVO [J].
ABE, E ;
CASAMENTI, F ;
GIOVANNELLI, L ;
SCALI, C ;
PEPEU, G .
BRAIN RESEARCH, 1994, 636 (01) :162-164
[2]   CALCIUM-BINDING PROTEINS - SELECTIVE MARKERS OF NERVE-CELLS [J].
ANDRESSEN, C ;
BLUMCKE, I ;
CELIO, MR .
CELL AND TISSUE RESEARCH, 1993, 271 (02) :181-208
[3]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[4]   IMMUNOAFFINITY PURIFICATION OF HUMAN CHOLINE-ACETYLTRANSFERASE - COMPARISON OF THE BRAIN AND PLACENTAL ENZYMES [J].
BRUCE, G ;
WAINER, BH ;
HERSH, LB .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (02) :611-620
[5]   CALBINDIN-D-28K AND PARVALBUMIN IN THE RAT NERVOUS-SYSTEM [J].
CELIO, MR .
NEUROSCIENCE, 1990, 35 (02) :375-475
[6]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[7]   AF64A AFFECTS SEPTAL CHOLINE-ACETYLTRANSFERASE BUT NOT PARVALBUMIN-IMMUNOREACTIVE CELLS [J].
DONG, XW ;
HANIN, I ;
LORENS, SA .
BRAIN RESEARCH BULLETIN, 1994, 35 (03) :217-220
[8]   PARVALBUMIN-IMMUNOREACTIVE DYSTROPHIC NEURITES AND ABERRANT SPROUTS IN THE CEREBRAL-CORTEX OF PATIENTS WITH ALZHEIMERS-DISEASE [J].
FERRER, I ;
ZUJAR, MJ ;
RIVERA, R ;
SORIA, M ;
VIDAL, A ;
CASAS, R .
NEUROSCIENCE LETTERS, 1993, 158 (02) :163-166
[9]   GABAERGIC SEPTOHIPPOCAMPAL NEURONS CONTAIN PARVALBUMIN [J].
FREUND, TF .
BRAIN RESEARCH, 1989, 478 (02) :375-381
[10]   A RELIABLE AND SENSITIVE METHOD TO LOCALIZE TERMINAL DEGENERATION AND LYSOSOMES IN THE CENTRAL NERVOUS-SYSTEM [J].
GALLYAS, F ;
WOLFF, JR ;
BOTTCHER, H ;
ZABORSZKY, L .
STAIN TECHNOLOGY, 1980, 55 (05) :299-306